Rare diseases
Investigational molecules
Locations
Clinical trials in Norway – page 5678 clinical trials in Norway across 30 research sites in 54 cities. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)NorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayWhere most of the country's trials are run
Shares are of these cities' trials together.
54 cities, A–Z – pick yours to filter the trials
What the registry says about research in the country
Norway is conducting extensive clinical research in oncology, focusing on a wide range of malignancies. Trials are investigating novel immunotherapies, targeted therapies, and combination treatments for various cancers including non-small cell lung cancer, melanoma, breast cancer, and colorectal cancer. Research efforts emphasize personalized medicine approaches, particularly for tumors with specific genetic mutations such as KRAS G12C, EGFR mutations, and HER2 alterations.
Studies are evaluating checkpoint inhibitors, CAR T-cell therapies, and novel drug combinations to improve survival outcomes and quality of life for cancer patients across different stages of disease.
Clinical trials in Norway address major cardiovascular diseases with focus on prevention and treatment optimization. Research includes studies on atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation. Investigators are examining novel antiplatelet strategies, anticoagulation therapies, and interventions for patients undergoing cardiac procedures such as transcatheter aortic valve implantation.
These trials aim to establish optimal therapeutic strategies for reducing cardiovascular events and improving long-term outcomes in diverse patient populations.
Norwegian research sites participate in trials targeting neurological diseases and neurodegenerative conditions. Studies focus on Alzheimer's disease, dementia with Lewy bodies, multiple sclerosis, and amyotrophic lateral sclerosis. Trials are evaluating disease-modifying therapies, symptomatic treatments, and novel approaches to slow disease progression.
Research emphasizes both pharmacological and non-pharmacological interventions to address the complex needs of patients with neurological disorders.
Trials in Norway investigate treatments for various autoimmune conditions and inflammatory diseases. Research covers rheumatoid arthritis, inflammatory bowel disease including Crohn's disease and ulcerative colitis, and systemic conditions such as systemic lupus erythematosus. Studies evaluate biologics, targeted synthetic disease-modifying drugs, and immunomodulatory therapies.
These trials aim to improve disease control, reduce inflammation, and enhance quality of life for patients with chronic autoimmune disorders.
Clinical research in Norway addresses major respiratory conditions including chronic obstructive pulmonary disease, asthma, and interstitial lung diseases. Studies focus on idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, and cystic fibrosis. Trials evaluate new bronchodilators, anti-inflammatory agents, and antifibrotic therapies.
Research aims to slow disease progression, improve lung function, and develop personalized treatment approaches for patients with chronic respiratory disorders.
Norwegian trials investigate metabolic diseases including diabetes mellitus, obesity, and lipid disorders. Research focuses on type 1 and type 2 diabetes, familial hypercholesterolemia, and complications such as diabetic neuropathy. Studies evaluate novel glucose-lowering agents, weight management interventions, and lipid-modifying therapies.
These studies aim to optimize metabolic control, prevent cardiovascular complications, and address the multifaceted challenges of metabolic diseases.
Research in Norway includes trials for rare genetic disorders and hereditary conditions. Studies address Fabry disease, achondroplasia, hemophilia, and various muscular dystrophies. Trials evaluate enzyme replacement therapies, gene therapies, and targeted treatments for specific genetic mutations.
These trials offer hope for patients with rare conditions through innovative therapeutic approaches and precision medicine strategies.
Clinical trials focus on kidney diseases and urological conditions. Research includes chronic kidney disease, IgA nephropathy, focal segmental glomerulosclerosis, and urothelial carcinomas. Studies evaluate treatments to preserve renal function, reduce proteinuria, and manage complications of kidney disease.
Research aims to slow disease progression, improve outcomes after transplantation, and develop effective therapies for renal malignancies.
Norwegian research addresses infectious diseases and immune system disorders. Trials investigate treatments for COVID-19, respiratory syncytial virus, and various bacterial and viral infections. Studies also focus on immune thrombocytopenia, graft-versus-host disease, and other immune-mediated conditions.
These trials aim to improve prevention strategies, develop targeted immunotherapies, and enhance outcomes for patients with infectious and immune-related diseases.
Research in hematology encompasses studies on hemic and lymphatic diseases. Trials investigate chronic lymphocytic leukemia, myelodysplastic syndromes, acute myeloid leukemia, and various lymphomas. Studies evaluate novel chemotherapy regimens, targeted therapies, and stem cell transplantation approaches.
These trials focus on improving survival rates, achieving deeper remissions, and minimizing treatment-related toxicities in patients with blood disorders.
Clinical trials address digestive system diseases including inflammatory bowel disease, celiac disease, and liver disorders. Research focuses on primary biliary cholangitis, primary sclerosing cholangitis, and non-alcoholic steatohepatitis. Studies evaluate immunomodulatory therapies, antifibrotic agents, and treatments to prevent disease progression.
Research aims to improve symptom control, prevent complications, and develop curative approaches for gastrointestinal malignancies.
Norwegian trials investigate mental health conditions including major depressive disorder, schizophrenia, and autism spectrum disorder. Research also addresses substance use disorders including dependencies on opioids, benzodiazepines, and amphetamines. Studies evaluate pharmacological interventions, behavioral therapies, and integrated treatment approaches.
These trials aim to improve symptom management, enhance quality of life, and develop effective interventions for complex psychiatric conditions.
Research includes trials for congenital and hereditary diseases affecting children. Studies address pediatric cancers, genetic disorders, and neonatal conditions such as hypoxic-ischemic encephalopathy. Trials evaluate age-appropriate formulations, dosing strategies, and treatments for rare pediatric conditions.
These studies focus on improving survival, minimizing long-term sequelae, and optimizing treatment approaches for children with serious medical conditions.
Clinical trials evaluate surgical techniques, perioperative care, and anesthesia approaches. Research includes studies on pain management, prevention of surgical complications, and optimization of recovery. Trials investigate both traditional surgical methods and minimally invasive approaches for various conditions.
Research aims to improve surgical outcomes, reduce complications, and enhance patient recovery across diverse surgical specialties.
Trials address eye diseases and sensory disorders including cataracts, Fuchs dystrophy, and thyroid eye disease. Research also investigates treatments for sudden sensorineural hearing loss, tinnitus, and vestibular disorders. Studies evaluate surgical techniques, medical therapies, and interventions to preserve or restore sensory function.
These trials focus on preserving vision and hearing, improving quality of life, and developing innovative treatments for sensory impairments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
